<?xml version="1.0" encoding="UTF-8"?>
<p>In order to rightly place the claims made in proper context with regards to the availability of research data, we have defined and categorized the claims reported in this review based on the relevance of different plants and plant products in COVID-19 management; consequently, to reveal what level of evidence exists for a reported plant, the following classifications have been described;
 <list list-type="simple">
  <list-item>
   <p>Level I evidence - Evidence from at least one clinical study.</p>
  </list-item>
  <list-item>
   <p>Level II evidence - Inferences supported by 
    <italic>in vivo</italic> experiments.
   </p>
  </list-item>
  <list-item>
   <p>Level III evidence - Detailed mechanistic and other 
    <italic>in vitro</italic> evaluations support the conclusion.
   </p>
  </list-item>
  <list-item>
   <p>Level IV evidence - Evidence from preliminary 
    <italic>in vitro</italic> screening or in silico data (IV*).
   </p>
  </list-item>
  <list-item>
   <p>Level V evidence - Claims are extrapolated from activities demonstrated against other similar viruses or in contextually related settings.</p>
  </list-item>
 </list>
</p>
